aPBI Re-irradiation

This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.

Trial Details

NCT ID
NCT07612254
Phase
PHASE1 / PHASE2
Sponsor
Dartmouth-Hitchcock Medical Center
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Reirradiation
Locations (sample)
  • Lebanon, New Hampshire, United States|43.64229,-72.25176

Key Eligibility Criteria

  • Patients who have histologically-confirmed, second, ipsilateral breast cancer which was diagnosed more than one year after completing breast conser…
  • Patients must have received prior radiotherapy to the breast
  • Patients must have an intact, involved breast.
  • Patients must meet ASTRO 2023 guidelines for a strong recommendation for partial breast irradiation.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →